Published in AIDS Weekly, September 27th, 1999
New studies show that even when given an hour after challenge with virulent, chimp-adapted HIV, the MAb completely protects against infection.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.